These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9325074)

  • 21. Pathogenic human monoclonal antibody against desmoglein 3.
    Yeh SW; Cavacini LA; Bhol KC; Lin MS; Kumar M; Duval M; Posner MR; Ahmed AR
    Clin Immunol; 2006 Jul; 120(1):68-75. PubMed ID: 16635589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic.
    Ding X; Diaz LA; Fairley JA; Giudice GJ; Liu Z
    J Invest Dermatol; 1999 May; 112(5):739-43. PubMed ID: 10233765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides.
    Dworschak J; Recke A; Freitag M; Ludwig RJ; Langenhan J; Kreuzer OJ; Zillikens D; Schmidt E
    J Dermatol Sci; 2012 Feb; 65(2):102-9. PubMed ID: 22261006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient.
    Ivars M; España A; Alzuguren P; Pelacho B; Lasarte JJ; López-Zabalza MJ
    Br J Dermatol; 2020 May; 182(5):1194-1204. PubMed ID: 31370093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between profile of circulating mononuclear cells and clinical manifestations in patients with pemphigus vulgaris.
    González A; España A; López-Zabalza MJ; Pelacho B; Sánchez-Carpintero I; Santiago E; López-Moratalla N
    Autoimmunity; 2000 Sep; 32(2):115-28. PubMed ID: 11078158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris.
    Ohyama M; Amagai M; Tsunoda K; Ota T; Koyasu S; Hata J; Umezawa A; Nishikawa T
    J Invest Dermatol; 2002 Jan; 118(1):199-204. PubMed ID: 11851895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
    Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.
    Tsunoda K; Ota T; Suzuki H; Ohyama M; Nagai T; Nishikawa T; Amagai M; Koyasu S
    Eur J Immunol; 2002 Mar; 32(3):627-33. PubMed ID: 11857336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
    Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
    Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune modulation in pemphigus vulgaris: role of CD28 and IL-10.
    Toto P; Feliciani C; Amerio P; Suzuki H; Wang B; Shivji GM; Woodley D; Sauder DN
    J Immunol; 2000 Jan; 164(1):522-9. PubMed ID: 10605050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris.
    Mimouni D; Blank M; Payne AS; Anhalt GJ; Avivi C; Barshack I; David M; Shoenfeld Y
    Clin Exp Immunol; 2010 Dec; 162(3):543-9. PubMed ID: 20964642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.
    Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M
    Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris.
    Schlögl E; Radeva MY; Vielmuth F; Schinner C; Waschke J; Spindler V
    Front Immunol; 2018; 9():858. PubMed ID: 29922278
    [No Abstract]   [Full Text] [Related]  

  • 36. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes.
    Aoyama Y; Owada MK; Kitajima Y
    Eur J Immunol; 1999 Jul; 29(7):2233-40. PubMed ID: 10427986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acantholysis may precede elevation of circulating anti-desmoglein 3 antibody levels in pemphigus vulgaris presenting with desquamative gingivitis.
    Endo H; Rees TD; Niwa H; Kuyama K; Oshima M; Serizawa T; Tanaka S; Komiya M; Ito T
    Clin Exp Dent Res; 2019 Jun; 5(3):219-224. PubMed ID: 31249702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris.
    Schmidt T; Willenborg S; Hünig T; Deeg CA; Sonderstrup G; Hertl M; Eming R
    Exp Dermatol; 2016 Apr; 25(4):293-8. PubMed ID: 26661498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desmosomal adhesion and pemphigus vulgaris: the first half of the story.
    Cirillo N; Al-Jandan BA
    Cell Commun Adhes; 2013 Feb; 20(1-2):1-10. PubMed ID: 23368972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering.
    Spindler V; Rötzer V; Dehner C; Kempf B; Gliem M; Radeva M; Hartlieb E; Harms GS; Schmidt E; Waschke J
    J Clin Invest; 2013 Feb; 123(2):800-11. PubMed ID: 23298835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.